Total Payments
$34,832
2024 Payments
$1,620
Companies
37
Transactions
538
Medicare Patients
4,786
Medicare Billing
$989,247
Payment Breakdown by Category
Food & Beverage$12,393 (35.6%)
Consulting$9,250 (26.6%)
Other$9,000 (25.8%)
Travel$4,062 (11.7%)
Education$126.52 (0.4%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $12,393 | 506 | 35.6% |
| Consulting Fee | $9,250 | 8 | 26.6% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $9,000 | 8 | 25.8% |
| Travel and Lodging | $4,062 | 8 | 11.7% |
| Education | $126.52 | 7 | 0.4% |
| Unspecified | $0 | 1 | 0.0% |
Payments by Type
General
$34,832
537 transactions
Ownership
$0
1 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $14,596 | 51 | $0 (2024) |
| Ironwood Pharmaceuticals, Inc | $7,047 | 23 | $0 (2018) |
| United Rheumatology | $2,950 | 2 | $0 (2017) |
| Amgen Inc. | $2,603 | 124 | $0 (2024) |
| PFIZER INC. | $806.38 | 54 | $0 (2024) |
| UCB, Inc. | $641.33 | 34 | $0 (2023) |
| Regeneron Healthcare Solutions, Inc. | $549.51 | 13 | $0 (2018) |
| E.R. Squibb & Sons, L.L.C. | $516.75 | 24 | $0 (2021) |
| Janssen Biotech, Inc. | $489.11 | 25 | $0 (2024) |
| Novo Nordisk Inc | $436.86 | 5 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,620 | 57 | Amgen Inc. ($450.50) |
| 2023 | $984.81 | 41 | Amgen Inc. ($407.12) |
| 2022 | $1,455 | 48 | Amgen Inc. ($402.17) |
| 2021 | $878.01 | 42 | Amgen Inc. ($441.91) |
| 2020 | $432.59 | 21 | Amgen Inc. ($305.36) |
| 2019 | $446.30 | 19 | Amgen Inc. ($231.26) |
| 2018 | $15,977 | 167 | Ironwood Pharmaceuticals, Inc ($6,925) |
| 2017 | $13,039 | 143 | AbbVie, Inc. ($7,678) |
All Payment Transactions
538 individual payment records from CMS Open Payments — Page 1 of 22
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $15.89 | General |
| Category: Bone Health | ||||||
| 12/17/2024 | Amgen Inc. | Enbrel (Biological), Otezla | Food and Beverage | In-kind items and services | $11.25 | General |
| Category: Inflammation | ||||||
| 12/16/2024 | GlaxoSmithKline, LLC. | BENLYSTA (Biological), NUCALA | Food and Beverage | In-kind items and services | $8.60 | General |
| Category: IMMUNOLOGY | ||||||
| 12/11/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $19.21 | General |
| Category: Bone Health | ||||||
| 12/10/2024 | Amgen Inc. | EVENITY (Biological) | Food and Beverage | In-kind items and services | $119.99 | General |
| Category: Bone Health | ||||||
| 12/05/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $9.30 | General |
| Category: Bone Health | ||||||
| 12/04/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $15.21 | General |
| Category: Immunology | ||||||
| 12/03/2024 | PFIZER INC. | XELJANZ (Drug) | Food and Beverage | In-kind items and services | $8.40 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 11/20/2024 | Amgen Inc. | EVENITY (Biological) | Food and Beverage | In-kind items and services | $123.00 | General |
| Category: Bone Health | ||||||
| 11/13/2024 | Organon Llc | RENFLEXIS (Drug), HADLIMA | Food and Beverage | In-kind items and services | $19.22 | General |
| Category: INFLIXIMAB | ||||||
| 11/07/2024 | Averitas Pharma Inc. | QUTENZA (Drug) | Food and Beverage | In-kind items and services | $131.99 | General |
| Category: PAIN MANAGEMENT | ||||||
| 11/07/2024 | GlaxoSmithKline, LLC. | BENLYSTA (Biological), NUCALA | Food and Beverage | In-kind items and services | $7.88 | General |
| Category: IMMUNOLOGY | ||||||
| 11/05/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $20.17 | General |
| Category: Immunology | ||||||
| 10/31/2024 | PFIZER INC. | XELJANZ (Drug) | Food and Beverage | In-kind items and services | $27.38 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 10/30/2024 | Amgen Inc. | Enbrel (Biological), Otezla | Food and Beverage | In-kind items and services | $8.48 | General |
| Category: Inflammation | ||||||
| 10/30/2024 | PFIZER INC. | XELJANZ (Drug) | Food and Beverage | In-kind items and services | $2.65 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 10/04/2024 | PFIZER INC. | XELJANZ (Drug) | Food and Beverage | In-kind items and services | $9.09 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 10/03/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $31.55 | General |
| Category: Immunology | ||||||
| 09/18/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $13.69 | General |
| Category: Immunology | ||||||
| 09/16/2024 | Amgen Inc. | — | Food and Beverage | In-kind items and services | $22.15 | General |
| 09/10/2024 | Organon Llc | — | Food and Beverage | In-kind items and services | $9.62 | General |
| 08/17/2024 | PFIZER INC. | XELJANZ (Drug) | Food and Beverage | In-kind items and services | $21.11 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 08/06/2024 | GlaxoSmithKline, LLC. | BENLYSTA (Biological) | Food and Beverage | In-kind items and services | $116.99 | General |
| Category: IMMUNOLOGY | ||||||
| 08/06/2024 | PFIZER INC. | XELJANZ (Drug) | Food and Beverage | In-kind items and services | $8.20 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 07/31/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $15.47 | General |
| Category: IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 1,282 | 18,592 | $593,980 | $309,838 |
| 2022 | 18 | 1,255 | 21,815 | $650,118 | $338,397 |
| 2021 | 15 | 1,233 | 6,735 | $363,786 | $212,819 |
| 2020 | 14 | 1,016 | 4,125 | $245,915 | $128,192 |
Total Patients
4,786
Total Services
51,267
Medicare Billing
$989,247
Procedure Codes
57
All Medicare Procedures & Services
57 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J3111 | Injection, romosozumab-aqqg, 1 mg | Office | 2023 | 12 | 13,640 | $191,233 | $105,974 | 55.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 556 | 1,118 | $214,713 | $104,987 | 48.9% |
| J0897 | Injection, denosumab, 1 mg | Office | 2023 | 49 | 2,940 | $88,200 | $52,037 | 59.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 157 | 157 | $40,035 | $18,480 | 46.2% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 78 | 78 | $26,520 | $12,900 | 48.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 94 | 107 | $14,980 | $6,540 | 43.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 38 | 41 | $11,275 | $5,264 | 46.7% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 176 | 329 | $1,974 | $1,935 | 98.0% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 88 | 145 | $4,495 | $1,393 | 31.0% |
| J1040 | Injection, methylprednisolone acetate, 80 mg | Office | 2023 | 34 | 37 | $555.00 | $329.54 | 59.4% |
| J0897 | Injection, denosumab, 1 mg | Office | 2022 | 71 | 6,480 | $194,100 | $110,835 | 57.1% |
| J3111 | Injection, romosozumab-aqqg, 1 mg | Office | 2022 | 15 | 13,440 | $188,429 | $100,929 | 53.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 440 | 879 | $167,985 | $79,771 | 47.5% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 74 | 74 | $25,112 | $12,354 | 49.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 83 | 83 | $21,153 | $10,213 | 48.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 64 | 72 | $19,635 | $9,289 | 47.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 71 | 79 | $11,030 | $5,131 | 46.5% |
| 96401 | Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | Office | 2022 | 42 | 42 | $4,998 | $1,908 | 38.2% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 75 | 155 | $4,805 | $1,664 | 34.6% |
| 73130 | X-ray of hand, minimum of 3 views | Office | 2022 | 25 | 25 | $2,304 | $1,320 | 57.3% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 184 | 320 | $1,920 | $948.93 | 49.4% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 11 | 11 | $1,870 | $904.73 | 48.4% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2022 | 14 | 20 | $1,880 | $894.20 | 47.6% |
| 72100 | X-ray of lower and sacral spine, 2-3 views | Office | 2022 | 27 | 27 | $1,404 | $782.20 | 55.7% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | Office | 2022 | 11 | 11 | $1,188 | $524.06 | 44.1% |
About Dr. Catherine Sullivan, MD
Dr. Catherine Sullivan, MD is a Rheumatology healthcare provider based in The Villages, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/20/2005. The National Provider Identifier (NPI) number assigned to this provider is 1548256100.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Catherine Sullivan, MD has received a total of $34,832 in payments from pharmaceutical and medical device companies, with $1,620 received in 2024. These payments were reported across 538 transactions from 37 companies. The most common payment nature is "Food and Beverage" ($12,393).
As a Medicare-enrolled provider, Sullivan has provided services to 4,786 Medicare beneficiaries, totaling 51,267 services with total Medicare billing of $989,247. Data is available for 4 years (2020–2023), covering 57 distinct procedure/service records.
Ad
Practice Information
- Specialty Rheumatology
- Other Specialties Rheumatology
- Location The Villages, FL
- Active Since 09/20/2005
- Last Updated 08/18/2025
- Taxonomy Code 207RR0500X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1548256100
Products in Payments
- Humira (Biological) $11,551
- DUZALLO (Drug) $6,963
- Enbrel (Biological) $1,423
- EVENITY (Biological) $931.83
- XELJANZ (Drug) $788.94
- Cimzia (Drug) $641.33
- KEVZARA SARILUMAB INJECTION (Biological) $549.51
- ACTHAR (Biological) $406.93
- ORENCIA (Biological) $397.96
- COSENTYX (Biological) $391.36
- TREMFYA (Drug) $379.70
- QUTENZA (Drug) $376.07
- Otezla (Drug) $338.78
- BENLYSTA (Biological) $234.12
- TEPEZZA (Drug) $226.27
- Tymlos (Biological) $201.44
- Prolia (Biological) $136.33
- Qutenza (Drug) $125.30
- Wegovy (Drug) $125.00
- RAYOS (Drug) $115.67
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.